What does Taiwan Advance Bio-Pharmaceutical Inc. do?

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 4186.TWO's market cap?

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) has a market capitalization of approximately $712.8 million, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 4186.TWO pay a dividend?

No — Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

4186.TWO

Taiwan Advance Bio-Pharmaceutical Inc.

TWO·Biotechnology · Healthcare

NT$7.92NT$0.10−1.25%

Market capNT$712.80M·Aug 26 6:59 AM UTC

Price Chart

NT$7.92−NT$0.10 (−1.25%)today

−57.53%CAGR −15.74%

Select date range

FromTo

Nov 27, 2012Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

4186.TWO does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)−33.8%

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$348.54M

Net IncomeNT$15.76M

Net Margin4.5%

Operating Cash FlowNT$55.53M

Capital ExpendituresNT$34.54M

Free Cash FlowNT$20.99M

Return on Equity5.9%

Return on Invested Capital−1.8%

Net DebtNT$141.65M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 4186.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 4186.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 4186.TWO and 80,000+ other tickers.

About Taiwan Advance Bio-Pharmaceutical Inc.

Taiwan Advance Bio-Pharmaceutical Inc. is a biotechnology enterprise with a substantial international presence, conducting operations across numerous countries such as China, Germany, the USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, and Pakistan, in addition to other global markets. Founded in 1989 and headquartered in New Taipei City, Taiwan, the company delivers a comprehensive array of products and services. Its offerings encompass diagnostic kits for ensuring food safety, alongside tailored customization services for ELISA, rapid, and chemical test kits, and expert…

CEO: Wen-Long Su
Sector: Healthcare
Industry: Biotechnology
Exchange: TWO
Employees: 160
Website: www.biotest.com.tw

Peers

Peers Tab

7725.TWO

LabTurbo Biotech Corporation

Cap

NT$1.1B

6810.TWO

Bio Preventive Medicine Corp.

Cap

NT$1.1B

6814.TWO

Lukas Biomedical Inc.

Cap

NT$833.3M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 4186.TWO

What does Taiwan Advance Bio-Pharmaceutical Inc. do?: Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 4186.TWO's market cap?: Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) has a market capitalization of approximately $712.8 million, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 4186.TWO pay a dividend?: No — Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.